ArticleMaterials today. Bio2026

Microbiota-derived self-adjuvanting exopolysaccharide-based codelivery system for potent cancer immunotherapy.

Xuemei Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.